Table 3.
The pathways may be associated with pulmonary fibrosis in profile 39 and 8
| Pathway | Profile | FoldEnrichment | P-value |
|---|---|---|---|
| Complement and coagulation cascades | 39 | 10.81239243 | 0.002570713 |
| Legionellosis | 39 | 10.31527094 | 0.015871597 |
| Central carbon metabolism in cancer | 39 | 9.496598639 | 0.018560791 |
| Rap1 signaling pathway | 39 | 4.135615537 | 0.034897583 |
| Protein digestion and absorption | 39 | 6.364741641 | 0.038990204 |
| Synthesis and degradation of ketone bodies | 8 | 33.10671937 | 0.029811592 |
| Nitrogen metabolism | 8 | 20.23188406 | 0.048337941 |
| Long-term depression | 8 | 11.74754558 | 0.012341775 |
| Renin secretion | 8 | 10.71099744 | 0.014720198 |
| Salivary secretion | 8 | 9.337792642 | 0.019085892 |
| Vascular smooth muscle contraction | 8 | 8.810659187 | 0.004517326 |
| Gap junction | 8 | 8.276679842 | 0.023929619 |
| Circadian entrainment | 8 | 7.357048748 | 0.029777868 |
| Tight junction | 8 | 6.426598465 | 0.010793826 |
| Thyroid hormone signaling pathway | 8 | 6.172439204 | 0.041065765 |
| Platelet activation | 8 | 5.646107179 | 0.048232816 |
| Human papillomavirus infection | 8 | 4.161987578 | 0.014133566 |